Abstract
Punctate inner choroidopathy (PIC) is a rare, idiopathic, inflammatory disease confined to the inner choroid and retinal pigment epithelium that occurs in otherwise healthy, predominantly young adult myopic women. PIC was first described in 1984 in a series of ten women by Watzke et al. [1]. In the largest series reported to date of 77 patients with the diagnosis of PIC who responded to a nationwide survey, 90 % of the patients were women, 85 % were myopic, and the median age of the participants was 30 years.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Watzke RC et al (1984) Punctate inner choroidopathy. Am J Ophthalmol 98(5):572–584
Gerstenblith AT et al (2007) Punctate inner choroidopathy: a survey analysis of 77 persons. Ophthalmology 114(6):1201–1204
Albert LJ, Inman RD (1999) Molecular mimicry and autoimmunity. N Engl J Med 341(27):2068–2074
Tiffin PA et al (1996) Indocyanine green angiography in a case of punctate inner choroidopathy. Br J Ophthalmol 80(1):90–91
Izatt JA et al (1994) Micrometer-scale resolution imaging of the anterior eye in vivo with optical coherence tomography. Arch Ophthalmol 112(12):1584–1589
Channa R et al (2012) Characterization of macular lesions in punctate inner choroidopathy with spectral domain optical coherence tomography. J Ophthalmic Inflamm Infect 2(3):113–120
Zhang X et al (2013) Spectral-domain optical coherence tomographic findings at each stage of punctate inner choroidopathy. Ophthalmology 120(12):2678–2683
Turkcuoglu P et al (2011) Mycophenolate mofetil and fundus autofluorescence in the management of recurrent punctate inner choroidopathy. Ocul Immunol Inflamm 19(4):286–292
Brueggeman RM, Noffke AS, Jampol LM (2002) Resolution of punctate inner choroidopathy lesions with oral prednisone therapy. Arch Ophthalmol 120(7):996
Levy J et al (2005) Punctate inner choroidopathy: resolution after oral steroid treatment and review of the literature. Can J Ophthalmol 40(5):605–608
Thorne JE et al (2005) Mycophenolate mofetil therapy for inflammatory eye disease. Ophthalmology 112(8):1472–1477
Cirino AC, Mathura JR Jr, Jampol LM (2006) Resolution of activity (choroiditis and choroidal neovascularization) of chronic recurrent punctate inner choroidopathy after treatment with interferon B-1A. Retina 26(9):1091–1092
Leslie T et al (2005) Photodynamic therapy for inflammatory choroidal neovascularisation unresponsive to immunosuppression. Br J Ophthalmol 89(2):147–150
Chatterjee S, Gibson JM (2003) Photodynamic therapy: a treatment option in choroidal neovascularisation secondary to punctate inner choroidopathy. Br J Ophthalmol 87(7):925–927
Verteporfin R et al (2002) Guidelines for using verteporfin (visudyne) in photodynamic therapy to treat choroidal neovascularization due to age-related macular degeneration and other causes. Retina 22(1):6–18
Bressler NM, Treatment of Age-Related Macular Degeneration with Photodynamic Therapy Study (2001) Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: two-year results of 2 randomized clinical trials-tap report 2. Arch Ophthalmol 119(2):198–207
Rogers AH et al (2002) Optical coherence tomography findings following photodynamic therapy of choroidal neovascularization. Am J Ophthalmol 134(4):566–576
Fong KC et al (2008) Photodynamic therapy combined with systemic corticosteroids for choroidal neovascularisation secondary to punctate inner choroidopathy. Eye (Lond) 22(4):528–533
Gragoudas ES et al (2004) Pegaptanib for neovascular age-related macular degeneration. N Engl J Med 351(27):2805–2816
Nguyen QD et al (2005) Bevacizumab suppresses choroidal neovascularisation caused by pathological myopia. Br J Ophthalmol 89(10):1368–1370
Michels S et al (2005) Systemic bevacizumab (Avastin) therapy for neovascular age-related macular degeneration twelve-week results of an uncontrolled open-label clinical study. Ophthalmology 112(6):1035–1047
Chan WM et al (2007) Intravitreal bevacizumab (avastin) for choroidal neovascularization secondary to central serous chorioretinopathy, secondary to punctate inner choroidopathy, or of idiopathic origin. Am J Ophthalmol 143(6):977–983
Persistent and recurrent neovascularization after krypton laser photocoagulation for neovascular lesions of ocular histoplasmosis. Macular Photocoagulation Study Group (1989) Arch Ophthalmol, 107(3):344–352
Eckstein M et al (1998) Surgical removal of non-age-related subfoveal choroidal neovascular membranes. Eye (Lond) 12(Pt 5):775–780
Melberg NS et al (1996) Managing recurrent neovascularization after subfoveal surgery in presumed ocular histoplasmosis syndrome. Ophthalmology 103(7):1064–1067, discussion 1067-8
Olsen TW et al (1996) Subfoveal choroidal neovascularization in punctate inner choroidopathy. Surgical management and pathologic findings. Ophthalmology 103(12):2061–2069
Coco RM, de Souza CF, Sanabria MR (2007) Photodynamic therapy for subfoveal and juxtafoveal choroidal neovascularization associated with punctate inner choroidopathy. Ocul Immunol Inflamm 15(1):27–29
Flaxel CJ et al (1998) The use of corticosteroids for choroidal neovascularisation in young patients. Eye (Lond) 12(Pt 2):266–272
Brown J Jr et al (1996) Visual prognosis of multifocal choroiditis, punctate inner choroidopathy, and the diffuse subretinal fibrosis syndrome. Ophthalmology 103(7):1100–1105
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
1 Electronic Supplementary Material
Below is the link to the electronic supplementary material.
Case Report 51
Puctate inner choroidopathy (PPTX 1760 kb)
Rights and permissions
Copyright information
© 2016 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Gerstenblith, A.T., Sepah, Y.J., Maya, J.R., Do, D.V., Nguyen, Q.D. (2016). Punctate Inner Choroidopathy. In: Zierhut, M., Pavesio, C., Ohno, S., Orefice, F., Rao, N. (eds) Intraocular Inflammation. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-75387-2_93
Download citation
DOI: https://doi.org/10.1007/978-3-540-75387-2_93
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-75385-8
Online ISBN: 978-3-540-75387-2
eBook Packages: MedicineMedicine (R0)